Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Plastic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics, 2001.CA Cancer J Clin. 2001; 51: 15-36
- Cancer statistics, 2015.CA Cancer J Clin. 2015; 65: 5-29
- Oncologic safety of conservative mastectomy in the therapeutic setting.Gland Surg. 2016; 5: 37-46
NCCN. NCCN clinical practice guidelines in oncology, breast cancer risk reduction. 2016. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast_risk.pdf. Accessed June 4, 2016.
- Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Cancer Prev Res (Phila). 2014; 7: 211-217
- Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.J Natl Cancer Inst. 2005; 97: 1428-1437
- Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.J Natl Cancer Inst. 1989; 81: 1879-1886
- Validation studies on a model for breast cancer risk.J Natl Cancer Inst. 1994; 86: 573-575
Project NCIaNSABaB. Breast cancer risk assessment tool. Available at: http://www.cancer.gov/bcrisktool/. Accessed June 1, 2016.
- Prophylactic mastectomy in women with a high risk of breast cancer.N Engl J Med. 1999; 340: 1838
- Role of surgery in the prophylaxis of hereditary cancer syndromes.Ann Surg Oncol. 2002; 9: 607-609
- Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?.Clin Breast Cancer. 2013; 13: 180-187
- Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.J Natl Cancer Inst. 2001; 93: 1633-1637
- Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.N Engl J Med. 2001; 345: 159-164
- Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.J Clin Oncol. 2004; 22: 1055-1062
- Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.N Engl J Med. 1999; 340: 77-84
- Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.J Clin Oncol. 2003; 21: 1675-1681
- A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.Arch Intern Med. 2005; 165: 516-520
- Prophylactic mastectomy in women with a high risk of breast cancer: correspondence.N Engl J Med. 1999; 320: 137-139
- Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment.Br J Cancer. 2003; 88: 1675-1681
- Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.J Natl Cancer Inst. 2002; 94: 1564-1569
- Predictors of and satisfaction with bilateral prophylactic mastectomy.Prev Med. 1995; 24: 412-419
- The current role of prophylactic mastectomy.Surg Clin North Am. 1996; 76: 231-242
- Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.J Clin Oncol. 2005; 23: 4275-4286
- Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.Am J Surg. 2000; 180: 439-445
- The woman at increased risk for breast cancer: evaluation and management strategies.CA Cancer J Clin. 1995; 45: 263-278
- Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.Am J Med Sci. 2012; 344: 452-456
- Prophylactic mastectomy in high risk patients: a practice-based review of the indications. Do we follow guidelines?.Breast Dis. 2010; 31: 19-27
- Women's decision-making roles regarding contralateral prophylactic mastectomy.J Natl Cancer Inst Monogr. 2005; : 55-60
- Occult malignancy in patients undergoing contralateral prophylactic mastectomy.Ann Surg. 2011; 254: 2-7
- The role of nipple-sparing mastectomy in breast cancer: a comprehensive review of the literature.Plast Reconstr Surg. 2013; 131: 969-984
- Nipple-areola complex preservation: predictive factors of neoplastic nipple-areola complex invasion.Ann Plast Surg. 2005; 55: 240-244
- Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy.Br J Surg. 2008; 95: 1356-1361
- Nipple involvement in breast cancer: retrospective analysis of 2323 consecutive mastectomy specimens.Int J Surg Pathol. 2011; 19: 328-334
- Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.J Clin Oncol. 2009; 27: 4948-4954
- Positive nipple margins in nipple-sparing mastectomies: rates, management, and oncologic safety.J Am Coll Surg. 2016; 222: 1149-1155
Article info
Publication history
Published online: September 29, 2017
Footnotes
Disclosure Statement: The authors have nothing to disclose.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
